1. The critical need to accelerate cerebral palsy research with consumer engagement, global networks, and adaptive designs.
- Author
-
Thomas, Sruthi P., Novak, Iona, Ritterband-Rosenbaum, Anina, Lind, Karin, Webb, Annabel, Gross, Paul, and McNamara, Maria
- Subjects
- *
CEREBRAL palsy prevention , *MIDDLE-income countries , *PATIENTS , *MENTAL illness , *CLINICAL medicine research , *HOSPITAL emergency services , *EMERGENCY medical services , *GLOBAL burden of disease , *NEUROLOGICAL disorders , *EXPERIMENTAL design , *MEDICAL research , *PRIORITY (Philosophy) , *QUALITY of life , *HEALTH information systems , *MEDICAL needs assessment , *PATIENT participation , *LOW-income countries ,RESEARCH evaluation - Abstract
The prevalence of cerebral palsy (CP) varies globally, with higher rates and burden of disease in low- and middle-income countries. CP is a lifelong condition with no cure, presenting diverse challenges such as motor impairment, epilepsy, and mental health disorders. Research progress has been made but more is needed, especially given consumer demands for faster advancements and improvements in the scientific evidence base for interventions. This paper explores three strategies to accelerate CP research: consumer engagement, global clinical trial networks, and adaptive designs. Consumer engagement involving individuals with lived experience enhances research outcomes. Global clinical trial networks provide efficiency through larger and more diverse participant pools. Adaptive designs, unlike traditional randomized controlled trials, allow real-time modifications based on interim analyses, potentially answering complex questions more efficiently. The establishment of a CP Global Clinical Trials Network, integrating consumer engagement, global collaboration, and adaptive designs, marks a paradigm shift. The Network aims to address consumer-set research priorities. While challenges like ethical considerations and capacity building exist, the potential benefits for consumers, clinicians, researchers, and funding bodies are substantial. This paper underscores the urgency of transforming CP research methodologies for quicker translation of novel treatments into clinical practice to improve quality of life for those with CP. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF